Kathleen Tregoning

Insider Reports History

Entity
Individual
Location
C/O Cerevel Therapeutics Holdings, Inc., 131 Dartmouth Street Suite 502, Boston, MA
Signature
/s/ Mark Bodenrader, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kathleen Tregoning:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Spero Therapeutics, Inc. Director Common Stock 55K $79.8K $1.45 May 29, 2024 Direct
Spero Therapeutics, Inc. Director Stock Option (Right to Buy) 35.6K $39.9K $1.12 Jan 2, 2024 Direct
Cerevel Therapeutics Holdings, Inc. Chief Corporate Affairs Officer Common Stock 0 $0 $41.18 Aug 1, 2024 Direct
Cerevel Therapeutics Holdings, Inc. Chief Corporate Affairs Officer Restricted Stock Units 0 $0 $41.18 Aug 1, 2024 Direct
Cerevel Therapeutics Holdings, Inc. Chief Corporate Affairs Officer Stock Option (Right to Buy) 0 Aug 1, 2024 Direct

Insider Reports Filed by Kathleen Tregoning

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CERE Cerevel Therapeutics Holdings, Inc. Aug 1, 2024 3 $0 4 Aug 5, 2024 Chief Corporate Affairs Officer
SPRO Spero Therapeutics, Inc. May 29, 2024 1 $0 4 May 30, 2024 Director
CERE Cerevel Therapeutics Holdings, Inc. Jan 19, 2024 1 $0 4 Jan 23, 2024 Title: Chief Corporate Affairs Officer
SPRO Spero Therapeutics, Inc. Jan 2, 2024 1 $39.9K 4 Jan 4, 2024 Director
CERE Cerevel Therapeutics Holdings, Inc. Dec 26, 2023 2 $31.7K 4 Dec 28, 2023 Title: Chief Corporate Affairs Officer
CERE Cerevel Therapeutics Holdings, Inc. Dec 19, 2023 3 -$260K 4 Dec 21, 2023 Title: Chief Corporate Affairs Officer
SPRO Spero Therapeutics, Inc. Oct 5, 2023 1 $0 4 Oct 10, 2023 Director
CERE Cerevel Therapeutics Holdings, Inc. Feb 6, 2023 2 $0 4 Feb 8, 2023 Exhibit 24 - Power of Attorney. Officer title: Chief Corporate Affairs Officer
SPRO Spero Therapeutics, Inc. Jan 3, 2023 1 $39.9K 4 Jan 5, 2023 Director
SPRO Spero Therapeutics, Inc. Sep 15, 2022 1 $0 4 Sep 19, 2022 Director
CERE Cerevel Therapeutics Holdings, Inc. Feb 9, 2022 1 $0 4 Feb 11, 2022 Chief Corporate Affairs Officer
SPRO Spero Therapeutics, Inc. Jan 5, 2022 1 $40K 4 Jan 7, 2022 Director
SPRO Spero Therapeutics, Inc. Nov 11, 2021 1 $0 4 Nov 12, 2021 Director
SPRO Spero Therapeutics, Inc. Oct 11, 2021 0 $0 3 Oct 14, 2021 Director